Hims & Hers (HIMS) is down -12.0%, or -$3.42 to $25.13.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Unusually active option classes on open December 19th
- Hims & Hers initiated with an Overweight at Morgan Stanley
- Ro, Lilly partnership creates volatility for Hims & Hers shares, says Leerink
- BofA views news of Lilly selling Zepbound through Ro as ‘mixed’ for Hims & Hers
- ADA advises doctors, patients not to use compounded GLP-1s